NASDAQ:LIXT

Lixte Biotechnology Earning Date

USA |NASDAQ |USD

LIXT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Sep 30, 2021 (est) Jun 30, 2021 - $-0.13 $-0.14
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Sep 30, 2021 (est) Jun 30, 2021 - $0.00 $0.00

Lixte Biotechnology's next estimated earnings date (based on same quarter last year's date) is Sep 30, 2021 for the fiscal quarter ending Jun 30, 2021.

LIXT Earnings Date & History Chart

LIXT Earnings Date & Revenue History

LIXT Earnings History

|
Show More
Show More

LIXT Revenue History

|
Show More
Show More

Lixte Biotechnology Next Earnings Date & Report

LIXT Jun 2021 (FQ) Earnings Date & Report Preview

LIXT's next estimated earnings date (based on same quarter last year's report date) is Sep 30, 2021 for the fiscal quarter ending Jun 30, 2021.

Lixte Biotechnology Previous Earnings Dates & Reports

LIXT Previous Earnings Date & Report Recap: Mar 2021 (FQ)

Lixte Biotechnology's previous earnings date was Jun 30, 2021 for its fiscal quarter ended Mar 31, 2021.

LIXT's earnings per share (EPS) was $-0.13.

The EPS was higher than the previous fiscal quarter (Dec 2020) by -6.06%, and lower than the same period a year before (Mar 2020) by 280.54%.

Revenues were $0.00.

The company reported a net income of $-1.73M.

Free cash flow for the quarter was $-1.03M , compared to $-1.38M last quarter and $-414.03K a year before.

LIXT Previous Earnings Date & Report Recap: Dec 2020 (FY)

Lixte Biotechnology's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

LIXT's earnings per share (EPS) was $-0.39.

Revenues were $0.00.

The company reported a net income of $-3.26M.

Lixte Biotechnology reported a free cash flow of $-2.13M for its fiscal year, compared to $-1.67M a year ago.